Table 2.
Best-ranked CpGs for the exposure intervention and therapy.
| CpG | P value | Q value | Bio rank | Stat rank | Sum rank | Gene |
|---|---|---|---|---|---|---|
| Exposure | ||||||
| cg01586609 | 4.3 × 10−5 | 0.83 | 53 | 60 | 113 | HTR3A |
| cg02279108 | 2.95 × 10−5 | 0.85 | 419 | 214 | 633 | MNX1-AS1 |
| cg27120833 | 1.63 × 10−4 | 0.89 | 35 | 620 | 655 | ARFGAP3 |
| cg13927247 | 2.2 × 10−4 | 0.87 | 448 | 290 | 738 | DTWD2 |
| cg03002526 | 1.9 × 10−4 | 0.87 | 673 | 305 | 978 | HACE1 |
| cg09855140 | 2.38 × 10−4 | 0.91 | 205 | 1044 | 1249 | FKSG29 |
| cg20611272 | 2 × 10−4 | 0.86 | 1068 | 251 | 1319 | ODF1 |
| cg07428959 | 9.7 × 10−5 | 0.90 | 445 | 885 | 1330 | JADE1 |
| cg13857354 | 5.7 × 10−5 | 0.91 | 172 | 1219 | 1391 | RNPEPL1 |
| cg13054007 | 2.4 × 10−4 | 0.87 | 1180 | 271 | 1451 | SPRY2 |
| Therapy | ||||||
| cg01848660 | 1.00 × 10−4 | 1 | 124 | 42 | 166 | C1D |
| cg23839680 | 3.03 × 10−4 | 1 | 180 | 153 | 333 | PSPH |
| cg07205203 | 3.43 × 10−4 | 1 | 211 | 175 | 386 | PPP1CB |
| cg03308839 | 2.34 × 10−4 | 1 | 584 | 107 | 691 | NDE1 |
| cg09160681 | 6.62 × 10−4 | 1 | 553 | 323 | 876 | PARM1 |
| cg12594803 | 1.74 × 10−3 | 1 | 28 | 873 | 901 | DLG1 |
| cg19676182 | 1.26 × 10−3 | 1 | 471 | 624 | 1095 | CCDC149 |
| cg20956594 | 8.78 × 10−4 | 1 | 701 | 425 | 1126 | POMP |
| cg15210526 | 2.27 × 10−4 | 1 | 1054 | 103 | 1157 | MPZL1 |
| cg25853622 | 1.19 × 10−3 | 1 | 699 | 590 | 1289 | LPP |
This Table displays the 10 best CpGs ranked according to the cumulative, statistical and biological ranking (see “Methods”) for the exposure intervention and therapy respectively. The p value column reports the p value for the effect of time in the selected model. The Q value columns reports the corresponding p value after multiple testing correction. The Gene Column reports the gene annotated to the CpG.